DexCom Inc. ($DXCM) Stock Forecast: Up 5.1% Today

What is DexCom Inc.?

DexCom, Inc. (DXCM) is a company that specializes in continuous glucose monitoring systems for diabetes management. The stock showed significant bullish movement in the market today.

Why is DexCom Inc. going up?

DXCM stock is up 5.1% on Nov 13, 2025 14:50

• An upcoming lead plaintiff deadline in a securities lawsuit may have initially caused volatility in the stock.
• Despite bearish opinions in the options market, positive news surrounding DXCM's strong growth in Q3 and focus on innovation likely reassured investors and supported the bullish movement.
• Ongoing securities fraud class action lawsuits and legal reminders could have led to short-term fluctuations. However, the overall positive view on DXCM's performance and market position has been more prominent, driving the bullish trend.
• Investors appear to be placing more emphasis on the company's growth potential and competitive standing rather than its legal challenges, leading to an increase in the stock price.

DXCM Price Chart

DXCM Technical Analysis

DXCM News

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM - DexCom ( NASDAQ:DXCM )

NEW YORK, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ( "DexCom, Inc." or the "Company" ) ( NASDAQ:DXCM ) of a class action securities lawsuit.

https://www.benzinga.com/pressreleases/25/11/g48792217/levi-korsinsky-reminds-shareholders-of-a-lead-plaintiff-deadline-of-december-26-2025-in-dexcom-inc

Decoding DexCom's Options Activity: What's the Big Picture? - DexCom ( NASDAQ:DXCM )

Whales with a lot of money to spend have taken a noticeably bearish stance on DexCom. Looking at options history for DexCom ( NASDAQ:DXCM ) we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish ...

https://www.benzinga.com/insights/options/25/11/48788480/decoding-dexcoms-options-activity-whats-the-big-picture

Here's Why You Should Hold DexCom Stock in Your Portfolio for Now

DXCM's strong Q3 growth, expanding CGM coverage and innovation-driven momentum position it for sustained adoption despite rising competition.

https://www.zacks.com/stock/news/2789529/heres-why-you-should-hold-dexcom-stock-in-your-portfolio-for-now

Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and an Expanded Class Period - DexCom ( NASDAQ:DXCM )

RADNOR, Pa. , Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that securities class action lawsuits have been filed against DexCom, Inc. ( "DexCom" ) ( NASDAQ:DXCM ) on behalf of those who purchased or otherwise acquired ...

https://www.benzinga.com/pressreleases/25/11/g48768719/kessler-topaz-meltzer-check-llp-reminds-dexcom-inc-investors-of-important-deadline-in-securities-f

DexCom, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM - DexCom ( NASDAQ:DXCM )

NEW YORK, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. ( NASDAQ:DXCM ) . Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...

https://www.benzinga.com/pressreleases/25/11/g48765017/dexcom-inc-sued-for-securities-law-violations-contact-the-gross-law-firm-before-december-26-2025-t

Trending Today

Jefferies Financial Group Inc. ($JEF) Stock Forecast: Down 5.3% Today

S&P 500 Index ($SPX) Index Forecast: Down 2.0% Today

Cloudflare Inc. ($NET) Stock Forecast: Down 5.1% Today

Interactive Brokers Group, Inc. ($IBKR) Stock Forecast: Down 5.2% Today

Natural Gas ($GAS) Commodity Forecast: Down 5.0% Today

Blink Charging Co. ($BLNK) Stock Forecast: Down 6.2% Today

Roku Inc. ($ROKU) Stock Forecast: Down 5.1% Today

Fiverr International Ltd. ($FVRR) Stock Forecast: Down 5.6% Today

Plug Power Inc. ($PLUG) Stock Forecast: Down 5.0% Today

SoFi Technologies Inc. ($SOFI) Stock Forecast: Down 5.1% Today

DexCom Inc. Price History

11.10.2025 - DXCM Stock was up 5.7%

• The rise in DXCM's stock value may stem from investors perceiving the recent securities fraud class action lawsuits as temporary obstacles that DexCom will likely surmount.
• Despite the legal hurdles, investor confidence in DexCom's capacity to innovate within the healthcare technology industry could be bolstering the stock's performance.
• Growing interest in the stock might also be a result of speculation surrounding potential resolutions or settlements related to the securities law violations, fostering a positive outlook among traders.

11.10.2025 - DXCM Stock was up 5.1%

• Today's bullish movement in DXCM's stock may be linked to the favorable market response to its robust Q3 growth and expanded CGM coverage, positioning the company for ongoing adoption despite growing competition.
• Despite facing legal challenges such as securities fraud class action lawsuits and allegations of securities law violations, investors appear to be more focused on the company's growth potential and momentum driven by innovation.
• While some investors have taken a bearish stance in the options market, this sentiment does not seem to have significantly impacted DXCM's stock performance today, as the overall optimistic outlook on the company's future prospects overshadowed these issues.

13.10.2025 - DXCM Stock was up 5.1%

• An upcoming lead plaintiff deadline in a securities lawsuit may have initially caused volatility in the stock.
• Despite bearish opinions in the options market, positive news surrounding DXCM's strong growth in Q3 and focus on innovation likely reassured investors and supported the bullish movement.
• Ongoing securities fraud class action lawsuits and legal reminders could have led to short-term fluctuations. However, the overall positive view on DXCM's performance and market position has been more prominent, driving the bullish trend.
• Investors appear to be placing more emphasis on the company's growth potential and competitive standing rather than its legal challenges, leading to an increase in the stock price.

31.06.2025 - DXCM Stock was down 8.0%

• Despite surpassing Q2 earnings and increasing 2025 sales outlook, DXCM's stock faced a decline as margin pressure impacted investor sentiment.
• The company's strong financial results were overshadowed by worries about margins, resulting in the bearish movement of the stock.
• Expectations for better performance beyond the reported figures might have led to disillusionment among investors, contributing to the drop in stock value.

31.06.2025 - DXCM Stock was down 6.6%

• The noticeable decline in DXCM stock today is possibly linked to profit-taking by investors following a recent uptrend.
• While DexCom (DXCM) surpassed earnings and revenue expectations in Q2, the market reaction may reflect heightened anticipated results, resulting in a sell-off.
• Investor apprehension regarding DexCom's growth sustainability, coupled with uncertainties surrounding U.S. coverage expansion and Stelo's impact, could be influencing market sentiment.
• A shift in overall market sentiment, influenced by various factors, may be leading some traders to approach DXCM stock more cautiously.

19.08.2025 - DXCM Stock was down 5.5%

• The decline in DXCM stock today could be linked to a recent claim suggesting that the company sold faulty G7 devices flagged by the FDA. Incidents of hospitalizations and alleged deaths associated with the G7 device may have raised concerns among investors about the product's quality and regulatory consequences.
• Ongoing investigations by legal firms looking into potential claims and breaches of fiduciary duties by DexCom's executives could have contributed to the negative sentiment towards the stock, prompting the bearish market performance.
• Investor response may be tied to uncertainties and legal inquiries surrounding DexCom, Inc., influencing the stock's trajectory as stakeholders weigh the potential risks and ramifications of the investigations on the company's future prospects.

25.08.2025 - DXCM Stock was down 5.0%

• An ongoing investigation related to investor claims may have introduced uncertainty and pessimism into the stock, resulting in its bearish movement.
• Increased bearish options activity by well-funded investors might have exacerbated the downward trend of DXCM shares.
• Allegations surrounding the sale of faulty G7 devices by Dexcom, leading to adverse events and FDA citations for unauthorized changes affecting accuracy, likely influenced the negative market sentiment and the stock's bearish movement.

07.10.2025 - DXCM Stock was down 5.1%

• The decrease in DXCM stock value might be linked to legal actions taken against the company alleging securities fraud, which has caused uncertainty among investors.
• Despite reporting strong double-digit growth in Q3 earnings and increasing its projected revenue for 2025, the stock price dropped, potentially indicating that the legal issues have overshadowed the positive financial performance.
• Investor sentiment towards DXCM appears pessimistic, possibly driven by worries concerning the lawsuits' impact on the company's image and long-term growth prospects.

31.09.2025 - DXCM Stock was down 15.0%

• Despite surpassing earnings and revenue estimates in Q3, DexCom's stock experienced a bearish movement possibly due to ongoing securities class action lawsuits.
• Investor uncertainty may have increased as investigations into potential breaches of fiduciary duties by certain officers and directors were revealed, further impacting confidence in the company.
• Analysts initially highlighted positive earnings growth potential, but the overshadowing legal issues and declining short interest may have contributed to the bearish market movement today.

31.09.2025 - DXCM Stock was down 13.7%

• The filing of class action lawsuits against DexCom Inc. by multiple law firms likely influenced the stock's bearish performance.
• Despite exceeding Q3 earnings and revenue expectations, legal issues facing the company may have dampened the impact of positive financial results.
• The decline in short interest may suggest a waning confidence or increased uncertainty among investors about the company's future trajectory.
• Legal disputes and uncertainties surrounding DexCom Inc. might have eroded investor trust, contributing to the bearish trend witnessed in the market today.

31.09.2025 - DXCM Stock was down 14.3%

• Despite strong growth in Q3 and an increase in revenue projections for 2025, DXCM saw a decline in its stock price, signaling a disconnect between its performance and investor expectations.
• An ongoing examination into potential breaches of fiduciary duties by certain company officials could have contributed to investor unease and the stock's bearish performance.
• Legal actions initiated by a law firm on behalf of DXCM investors within a specific timeframe might have added to the negative market sentiment surrounding the company.
• Even surpassing Q3 earnings and revenue forecasts may not have been enough to counterbalance overarching market apprehensions and legal uncertainties, resulting in the decline in the stock's value.

25.07.2025 - DXCM Stock was down 3.0%

• DXCM's expansion efforts and focus on innovation with type 2 access, Stelo adoption, and new sensor launches have been positive for the company.
• However, margin pressures, increasing competition, and a leadership transition may have contributed to investor concerns, leading to the bearish movement in the stock price.
• The balancing act between growth opportunities and challenges in the market could be causing uncertainty among investors, resulting in the downward trend for DXCM today.